Blood glucose, glucose balance, and disease-specific survival after prostate cancer diagnosis in the Finnish Randomized Study of Screening for Prostate Cancer
The DOI matches its Crossref record; 26 of the 27 references it cites were found in a registry or an index.
Abstract
Introduction Diabetes mellitus has been linked with adverse prostate cancer (PCa) outcomes. However, role of hyperglycemia in PCa progression is unclear. We evaluated the link between hyperglycemia and PCa survival among Finnish PCa patients. Methods The study cohort included 1770 men with data on fasting glucose and diagnosed with PCa within the Finnish Randomized Study of Screening for PCa in 1995-2009. Additionally, 1398 men had data on glycated hemoglobin (HbA1c). Information on fasting glucose and HbA1c measurements was obtained from the regional laboratory database. Antidiabetic medication use was obtained from the prescription database of the Social Insurance Institution (SII). Time-dependent Cox regression analysis was used to estimate hazard ratios (HRs) and 95% confidence intervals for PCa death among diabetic, impaired glucose tolerant, and normoglycemic men. Results During median follow-up of 9.9 years after the diagnosis, 182 men died from PCa. After adjustment for tumor stage, Gleason grade, and PSA level at diagnosis, diabetic fasting glucose level after PCa diagnosis was associated with elevated risk of PCa death compared to normoglycemic men (HR 1.67 95% CI 1.18-2.36). The risk association was strongest among participants with localized cancer at diagnosis; HR 2.39, 95% CI 1.45-3.93. The risk elevation was observed for glucose measurements taken up to 5 years earlier. Diabetic glucose levels measured before the diagnosis were not associated with PCa death. Co…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In premenopausal women, increased BMI may be protective overall for breast cancer1759”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [1759]
Citations
Cites
Giovannucci, E., & Michaud, D. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.03.050 · Cited by 543
Role of Diet in Prostate Cancer Development and Progression
Chan, J. M., Gann, P. H., & Giovannucci, E. L. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.03.1492 · Cited by 413
Obesity, metabolic syndrome, and prostate cancer
Hsing, A. W., Sakoda, L. C., & Chua, S. C. (2007) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/86.3.843s · Cited by 344
Hyperglycemia as a Risk Factor for Cancer Progression
Ryu, T. Y., Park, J., & Scherer, P. E. (2014) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2014.38.5.330 · Cited by 331
Smoking as a Risk Factor for Prostate Cancer: A Meta-Analysis of 24 Prospective Cohort Studies
Huncharek, M., Haddock, K. S., Reid, R., & Kupelnick, B. (2010) · American Journal of Public Health · doi:10.2105/ajph.2008.150508 · Cited by 312
Prostate Cancer Risk and Serum Levels of Insulin and Leptin: a Population-Based Study
Hsing, A. W., Chua, S., Gao, Y.-T., Gentzschein, E., Chang, L., Deng, J., & Stanczyk, F. Z. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.10.783 · Cited by 298
Richman, E. L., Kenfield, S. A., Stampfer, M. J., Paciorek, A., Carroll, P. R., & Chan, J. M. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-3932 · Cited by 297
Diabetes mellitus and cancer risk: Review of the epidemiological evidence
Shikata, K., Ninomiya, T., & Kiyohara, Y. (2013) · Cancer Science · doi:10.1111/cas.12043 · Cited by 245
Masur, K., Vetter, C., Hinz, A., Tomas, N., Henrich, H., Niggemann, B., & Zänker, K. S. (2011) · British Journal of Cancer · doi:10.1038/sj.bjc.6606050 · Cited by 153
Prostate Cancer Mortality in the Finnish Randomized Screening Trial
Kilpeläinen, T. P., Tammela, T. L. J., Malila, N. K., Hakama, M., Santti, H., Määttänen, L., Stenman, U., Kujala, P. M., & Auvinen, A. P. (2013) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djt038 · Cited by 112
Self-citation
Cited by
Blonde, L., Umpierrez, G. E., Reddy, S. S., McGill, J. B., Berga, S. L., Bush, M., Chandrasekaran, S., DeFronzo, R. A., Einhorn, D., Galindo, R. J., et al. (2022) · Endocrine Practice · doi:10.1016/j.eprac.2022.08.002 · Cited by 507
Zhou, Y., Li, T., Muheiyati, G., Duan, Y., Xiao, S., Gao, Y., Tao, N., & An, H. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1280221 · Cited by 18
Frankó, A., Berti, L., Hennenlotter, J., Rausch, S., Scharpf, M. O., de Angelis, M. H., Stenzl, A., Peter, A., Birkenfeld, A. L., Lutz, S. Z., et al. (2020) · Biomedicines · doi:10.3390/biomedicines8110507 · Cited by 12
“In line, poorer prognosis was reported in men with PCa and elevated blood glucose [39,40].”
BackgroundAntidiabetic Drugs and Prostate Cancer Prognosis in a Finnish Population-Based Cohort
Vihervuori, V., Talala, K. M., Taari, K., Lahtela, J. T., Tammela, T. L. J., Auvinen, A. P., Raittinen, P. V. H., & Murtola, T. J. (2021) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-19-0580 · Cited by 7
Self-citationJoentausta, R. M., Rannikko, A. S., & Murtola, T. J. (2021) · European Urology Open Science · doi:10.1016/j.euros.2021.10.002 · Cited by 6
“Among diabetic men, poor glycemic control seems to be associated with increased risks of metastatic and castration-resistant PCa [4] and PCa death [5].”
BackgroundSelf-citation
Metadata
- Authors
- Murtola, T. J., Sälli, S. M., Talala, K., Taari, K., Tammela, T. L. J., & Auvinen, A.
- Affiliations
- Tampere University (FI)
- Finnish Cancer Registry (FI)
- University of Helsinki (FI)
- Corresponding author
- Murtola, Teemu J.
- Venue
- Prostate Cancer and Prostatic Diseases
- Published
- 2019-01-24
- Volume
- 22
- Issue
- 3
- Pages
- 453-460
- ISSN
- 1365-7852 (ISSN-L)
- 1476-5608
- OpenAlex
- W2914752208
- Cited by
- 13
- References
- 27
- Citations by year
- 2024: 5 · 2022: 3 · 2021: 4 · 2020: 1
- FWCI
- 0.66
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Prostate Cancer and Prostatic Diseases (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Health Sciences › Medicine › Urology › Prostate Cancer Diagnosis and Treatment
- Health Sciences › Medicine › Oncology › Inflammatory Biomarkers in Disease Prognosis
- Keywords
- prostate cancer, hyperglycemia, fasting blood glucose, HbA1c, diabetes mellitus, impaired glucose tolerance, prostate cancer mortality, disease-specific survival, tumor progression, localized prostate cancer, antidiabetic drugs
- MeSH terms
- Aged, Blood Glucose, Diabetes Mellitus, Type 2, Fasting, Finland, Follow-Up Studies, Glycated Hemoglobin, Humans, Hyperglycemia, Hypoglycemic Agents, Male, Mass Screening, Middle Aged, Neoplasm Staging, Prospective Studies, Prostate, Prostatic Neoplasms, Risk Factors, Survival Analysis, Prostate-Specific Antigen, Disease Progression, Risk Assessment, Neoplasm Grading
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Blood glucose, glucose balance, and disease-specific survival after prostate cancer diagnosis in the Finnish Randomized Study of Screening for Prostate Cancer. https://app.cochat.ai/papers/10.1038/s41391-018-0123-0
- The paper
- Murtola, T. J., Sälli, S. M., Talala, K., Taari, K., Tammela, T. L. J., & Auvinen, A. (2019). Blood glucose, glucose balance, and disease-specific survival after prostate cancer diagnosis in the Finnish Randomized Study of Screening for Prostate Cancer. Prostate Cancer and Prostatic Diseases. https://doi.org/10.1038/s41391-018-0123-0
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.